Chartwell Pharmaceuticals Congers, LLC

Form 483 issued September 26, 2018 · Congers, New York

Inspection
Sep 12 – Sep 26, 2018
Investigator
Sony Mathews
Observations
4
Pages
3
FEI number
3008897678

In short: On September 26, 2018, FDA issued a Form 483 with 4 observations to Chartwell Pharmaceuticals Congers, LLC in Congers, New York (FEI 3008897678) after an inspection that ran Sep 12 – Sep 26, 2018. The investigator was Sony Mathews. Most observations concern facilities & equipment and materials.

At a glance

Facilities & equipment and materials account for 3 of 4 observations.

Facilities & equipment2
Materials1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in…

  2. 02

    Procedures describing the warehousing of drug…

  3. 03

    The responsibilities and procedures applicable to the quality control unit are not in…

  4. 04

    The building lacks adequate space for the orderly placement of equipment and materials to prevent mix…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Chartwell Pharmaceuticals Congers, LLC?

FDA listed 4 observations on this Form 483, mostly about facilities & equipment, materials and quality system. The opening words of each observation are shown on this page.

Who inspected Chartwell Pharmaceuticals Congers, LLC?

Sony Mathews is named on this Form 483, for the inspection of Sep 12 – Sep 26, 2018. Each investigator has a profile showing what they cite most.

When was Chartwell Pharmaceuticals Congers, LLC inspected by FDA?

The inspection ran Sep 12 – Sep 26, 2018, and the Form 483 is dated September 26, 2018.

How do I get the full Form 483 for Chartwell Pharmaceuticals Congers, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free